Johnson & Johnson Equity 2024

Johnson & Johnson Aktienanalyse

What does Johnson & Johnson do?

Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Johnson & Johnson's Equity

Johnson & Johnson's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Johnson & Johnson's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Johnson & Johnson's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Johnson & Johnson's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Johnson & Johnson’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Johnson & Johnson Stock

What is the equity of Johnson & Johnson this year?

Johnson & Johnson has equity of 68.77 B USD this year.

What was the equity of Johnson & Johnson compared to the previous year?

The equity of Johnson & Johnson has increased/decreased by -10.46% decreased compared to the previous year.

What impact does a high equity have on investors of Johnson & Johnson?

A high equity is advantageous for investors of Johnson & Johnson as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Johnson & Johnson?

A low equity can be a risk for investors of Johnson & Johnson, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Johnson & Johnson affect the company?

An increase in equity of Johnson & Johnson can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Johnson & Johnson affect the company?

A reduction in equity of Johnson & Johnson can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Johnson & Johnson?

Some factors that can affect the equity of Johnson & Johnson include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Johnson & Johnson so important for investors?

The equity of Johnson & Johnson is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Johnson & Johnson take to change the equity?

To change equity, Johnson & Johnson can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Johnson & Johnson pay?

Over the past 12 months, Johnson & Johnson paid a dividend of 4.7 USD . This corresponds to a dividend yield of about 3.22 %. For the coming 12 months, Johnson & Johnson is expected to pay a dividend of 5.1 USD.

What is the dividend yield of Johnson & Johnson?

The current dividend yield of Johnson & Johnson is 3.22 %.

When does Johnson & Johnson pay dividends?

Johnson & Johnson pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Johnson & Johnson?

Johnson & Johnson paid dividends every year for the past 63 years.

What is the dividend of Johnson & Johnson?

For the upcoming 12 months, dividends amounting to 5.1 USD are expected. This corresponds to a dividend yield of 3.49 %.

In which sector is Johnson & Johnson located?

Johnson & Johnson is assigned to the 'Health' sector.

Wann musste ich die Aktien von Johnson & Johnson kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Johnson & Johnson from 6/4/2024 amounting to 1.24 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Johnson & Johnson pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Johnson & Johnson in the year 2023?

In the year 2023, Johnson & Johnson distributed 4.45 USD as dividends.

In which currency does Johnson & Johnson pay out the dividend?

The dividends of Johnson & Johnson are distributed in USD.